Science keeps winning! Scientists recently transplanted a pig’s kidney into a human being without immediate rejection by the immune system.
A step in the right direction, the achievement could help ease the shortage of human organs for transplant by using animal organs.
Performed at the NYU Langone Health in New York City, the procedure used the kidney of a pig whose genes had been modified to get rid of a particular molecule which causes human immune systems to reject animal organs.
According to Reuters, the recipient of the pig kidney is a comatose patient who was experiencing kidney dysfunction. The subject’s family consented to the pig kidney transplantation before she was set to be taken off life support.
How was the procedure done?
In the pilot phase of the transplant, the pig kidney was attached to her blood vessels but kept outside the body. This gave researchers access to the kidney for three days in case things were to go awry.
The kidney function after the transplant appears to be normal so far. Turns out the kidney is also making as much urine as expected from a kidney. In fact, Dr. Robert Montgomery, the lead researcher of the study told Reuters that it’s working akin to a human kidney.
The most telling sign of the pig kidney working? The recipient’s kidney function has become normal again. Earlier, the subject’s creatinine levels were abnormal and now they appear stable.
Kidney shortage in India
Researchers across the globe have been working for decades to transplant animal kidneys into humans. Unfortunately, the immediate rejection has remained extremely high among recipients. With this new pig kidney transplant, things may be headed for a shake-up.
According to Narayana Health, almost 200,000 patients in India are awaiting organ donation with only 15,000 available donors. This gap could be filled with animal transplants modelled around this one.
Reference:
https://www.indiatimes.com/technology/science-and-future/pig-kidney-transplant-in-human-552148.html
Highly potent active pharmaceutical ingredients (HPAPIs) are at the dangers of cross-contamination with other product forefront of pharmaceutical manufacturing. They are particularly common in targeted therapies and personalized medicines. This is primarily due to their potent therapeutic effects at low dosage forms.
The floating traffic jams off ports. The multiplying costs of moving freight. The resulting shortages of goods. All of this had seemed like an unpleasant memory confined to the COVID-19 pandemic. But no such luck!
An ocean container capacity crunch has hit global trade just as peak shipping season starts, with freight spot rates up some 30% over the past few weeks and heading higher.
The first joint Europe-wide assessment of the drivers and impact of chemical pollution by the European Environment Agency (EEA) and the European Chemicals Agency (ECHA) has concluded that, despite progress in some areas, “more work is still needed to reduce the impact of harmful substances on human health and the environment”. Key findings include:
The severe drought which has forced the Panama Canal, one of the world’s busiest trade passages, to limit daily crossings could impact global supply chains during a period of high demand.
In the early hours of March 26, the Singapore-flagged ship Dali, loaded with 5,000 containers, slammed into Baltimore’s Francis Scott Key Bridge, causing the 1.6-mile (2.5-kilometer) bridge to collapse in a matter of seconds. The Dali was departing for Colombo when the disaster struck. Initial fears were confirmed that half a dozen people lost their lives in the accident.
The pharmaceutical and biotechnology industries constantly seek innovative methods to enhance product stability, solubility, bioavailability and ease of use. Within this realm, CDMOs [Contract Development & Manufacturing Organizations] serve as invaluable partners in the development and production of high-quality drug products.
Chinese New Year 2024 is upon us, disrupting logistics from Asia starting Feb 10th. This event is expected to impact global shipping until Feb 21. Freight rates from Asia has skyrocketed with rates to the US surging by 3.5X and Europe by 6X.
Amid ongoing Red Sea diversions by shipping giants like Maersk, CMA, logistics managers are globally confronting a dual challenge of escalating ocean and air freight prices alongside cargo disruptions due to